Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07450872) titled 'Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors' on Feb. 27.

Study Type: Observational [Patient Registry]

Primary Sponsor: The Children's Hospital of Zhejiang University School of Medicine

Condition: Cancer Glioma Leukemia (Both ALL and AML)

Recruitment Status: Recruiting

Date of First Enrollment: January 1, 2026

Target Sample Size: 600

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07450872

Disclaimer: Curated by HT Syndication....